Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancer.
Hennemann
B
B
Department of Hematology and Oncology, Universität Freiburg, Federal Republic of Germany.
Scheibenbogen
C
C
Schümichen
C
C
Andreesen
R
R
D000368:Aged; D002277:Carcinoma / Q000276:immunology / Q000628:therapy; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000009:adverse effects / Q000379:methods; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000276:immunology* / Q000556:secondary / Q000628:therapy*; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology / Q000637:transplantation*; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000276:immunology / Q000628:therapy*